GNH USA

Europe — EMA

Muco Rhinathiol Enfants (Carbocisteine)

GNH USA supplies Muco Rhinathiol Enfants (Carbocisteine), a mucolytic for children with respiratory secretions and cough from bronchitis or sinusitis.

Request sourcing

1
Pack/s

What is Carbocisteine?

Carbocisteine, the active ingredient in Muco Rhinathiol Enfants, is a mucolytic presented as an oral pediatric formulation for use in children. It works to reduce the viscosity of thick respiratory secretions, facilitating easier expectoration and improve breathing comfort during illness.

GNH USA supplies Muco Rhinathiol Enfants as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution across.

What is Carbocisteine used for?

Muco Rhinathiol Enfants, a carbocisteine mucolytic, is used in pediatric respiratory conditions where thick mucus impairs airway clearance. - Thick respiratory secretions in children: helps thin mucus to improve expectoration. - Cough associated with acute bronchitis: reduces cough frequency by facilitating mucus clearance. - Sinusitis‑related cough in pediatric patients: alleviates cough by decreasing mucus viscosity in the nasal passages.

What are the side effects of Carbocisteine?

Carbocisteine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset that may occur after oral intake. - Vomiting: occasional episodes, especially with higher doses. - Diarrhea: loose stools reported in some children. - Skin rash: mild erythema or itching at the site of exposure.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Hepatic dysfunction: elevated liver enzymes or jaundice in rare cases. - Neutropenia: significant reduction in white blood cells, increasing infection risk.

What precautions apply to Carbocisteine?

When prescribing carbocisteine for children, several safety considerations should be observed. - Age restriction: avoid use in infants younger than two years unless specifically directed by a physician. - Renal impairment: adjust dose or monitor closely in children with reduced kidney function. - Hypersensitivity: discontinue if signs of allergic reaction such as rash or swelling appear. - Gastrointestinal irritation: monitor for persistent nausea, vomiting, or abdominal pain. - Concomitant mucolytics: avoid combining with other mucolytic agents without medical guidance. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

What does Carbocisteine interact with?

Carbocisteine may interact with certain medicines, influencing their effectiveness or safety.

Major Interactions (Avoid): - Other mucolytic agents: simultaneous use can increase risk of gastrointestinal upset. - Antitussives containing codeine: may reduce the expectorant effect of carbocisteine.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor coagulation parameters as carbocisteine may affect platelet function. - Antihistamines: observe for enhanced sedation or altered mucosal response. - Antibiotics (e.g., macrolides): watch for potential changes in drug absorption due to altered mucus viscosity.

Frequently asked questions

What is Muco Rhinathiol Enfants used for?+
Muco Rhinathiol Enfants is a pediatric mucolytic containing carbocisteine. It is used to thin thick respiratory secretions and to relieve cough associated with conditions such as acute bronchitis and sinusitis in children.
How does carbocisteine work?+
Carbocisteine reduces mucus viscosity by cleaving disulfide bonds in mucopolysaccharide chains. This chemical modification lowers the molecular weight of mucus, making it easier for ciliary action and coughing to clear the airways.
What is the usual dose of Muco Rhinathiol Enfants?+
The appropriate dose is determined by the prescribing healthcare professional based on the child’s age, weight, and clinical condition. Exact dosing instructions should be obtained from the prescriber and not inferred from product information.
Is Muco Rhinathiol Enfants safe during pregnancy or breastfeeding?+
Safety data for carbocisteine in pregnancy and lactation are limited. The product should only be used if the prescriber judges that the potential benefit outweighs any possible risk to the mother or infant.
How do I order Muco Rhinathiol Enfants from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com, where you specify the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Muco Rhinathiol Enfants compare with other mucolytics?+
Carbocisteine differs from agents such as N‑acetylcysteine by acting on disulfide bonds within mucus rather than providing a direct antioxidant effect. Both reduce viscosity, but carbocisteine is often preferred for its tolerability profile in children.
What are the storage and handling requirements?+
Store the product below 25 °C in its original packaging. Keep it away from moisture, direct sunlight and heat sources. Ensure the container is tightly closed to maintain product stability.
How is Muco Rhinathiol Enfants administered?+
The medication is taken orally, usually as a liquid suspension designed for children. It should be measured with a calibrated device and given according to the prescriber’s instructions, typically with or without food.
What are the most serious risks to watch for?+
Serious adverse reactions, although rare, include allergic responses such as hives, swelling or anaphylaxis, hepatic dysfunction indicated by jaundice or abnormal liver tests, and neutropenia which can increase infection risk. Immediate medical attention is required if these occur.
Who should not use Muco Rhinathiol Enfants?+
Children younger than two years, individuals with known hypersensitivity to carbocisteine, and patients with severe renal impairment should avoid this product unless a physician explicitly advises otherwise.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Carbocisteine
Route
Oral Use
Manufacturer
Opella Healthcare Belgium (Handelsnaam Sanofi Belgium)
Origin
EU

Related products